Production of low-avidity antibody by infants after infection with serogroup B meningococci.

Production of low-avidity antibody by infants after infection with serogroup B meningococci.

Experimental serogroup B meningococcal vaccines have induced only poor immune responses and have had little protective efficacy in children younger than 1 year of age. We used ELISA with potassium thiocyanate to compare the average avidity of antibody produced by infants with that of children older...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Pollard, A, Levin, M
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2000

Ижил төстэй зүйлс

Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
-н: C.A.C. Gioia, зэрэг

Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine Against Genetically Diverse Serogroup B Meningococci
-н: Giuntini, S, зэрэг
Хэвлэсэн: (2016)

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
-н: Cecilia Fazio, зэрэг
Хэвлэсэн: (2021-07-01)

Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy
-н: Paola Stefanelli, зэрэг
Хэвлэсэн: (2017-05-01)

Serogroup C meningococci in Italy in the era of conjugate menC vaccination
-н: Neri Arianna, зэрэг
Хэвлэсэн: (2009-08-01)

Cluster of Serogroup W135 Meningococci, Southeastern Florida, 2008–2009
-н: Timothy J. Doyle, зэрэг
Хэвлэсэн: (2010-01-01)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
-н: Alessandra Lo Presti, зэрэг
Хэвлэсэн: (2023-01-01)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017
-н: Alessandra Lo Presti, зэрэг
Хэвлэсэн: (2023-01-01)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
-н: Pollard, A, зэрэг
Хэвлэсэн: (2004)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America.
-н: Pollard, A, зэрэг
Хэвлэсэн: (2004)

Distribution of Serogroups of Neisseria meningitidis and Antigenic Characterization of Serogroup Y Meningococci in Canada, January 1, 1999 to June 30, 2001
-н: Raymond SW Tsang, зэрэг
Хэвлэсэн: (2002-01-01)

Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America
-н: Andrew J. Pollard, зэрэг
Хэвлэсэн: (2004-10-01)

Frequent capsule switching in 'ultra-virulent' meningococci - are we ready for a serogroup B ST-11 complex outbreak?
-н: Lucidarme, J, зэрэг
Хэвлэсэн: (2017)

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.
-н: Ibarz-Pavón, AB, зэрэг
Хэвлэсэн: (2011)

Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation
-н: Ibarz-Pavon, AB, зэрэг
Хэвлэсэн: (2011)

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
-н: Samy Taha, зэрэг
Хэвлэсэн: (2022-06-01)

Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.
-н: Christopher B Sullivan, зэрэг
Хэвлэсэн: (2015-01-01)

Opa protein repertoires of disease-causing and carried meningococci
-н: Callaghan, M, зэрэг
Хэвлэсэн: (2008)

Opa protein repertoires of disease-causing and carried meningococci
-н: Callaghan, M, зэрэг
Хэвлэсэн: (2008)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
-н: Emil Kupek, зэрэг

Retraction: Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines.
Хэвлэсэн: (2015-01-01)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
-н: Kupek Emil, зэрэг
Хэвлэсэн: (2001-01-01)

Age dependence of in vitro survival of meningococci in whole blood during childhood.
-н: Ison, C, зэрэг
Хэвлэсэн: (2003)

Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
-н: Kelly, D, зэрэг
Хэвлэсэн: (2009)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
-н: Aapo Knuutila, зэрэг
Хэвлэсэн: (2023-12-01)

Invasive infections due to group a streptococci and meningococci
-н: Jesús Ruiz-Contreras
Хэвлэсэн: (2019-11-01)

The beginning of the end for serogroup B meningococcus?
-н: Snape, MD, зэрэг
Хэвлэсэн: (2013)

The beginning of the end for serogroup B meningococcus?
-н: Snape, MD, зэрэг
Хэвлэсэн: (2013)

Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
-н: Bårnes, G, зэрэг
Хэвлэсэн: (2011)

Serogroup B meningococcal vaccines-an unfinished story.
-н: Sadarangani, M, зэрэг
Хэвлэсэн: (2010)

Clinical and economic estimation of children’s pharmacotherapy with meningococcial infections in Ukraine
-н: Iryna Bilyk, зэрэг
Хэвлэсэн: (2019-12-01)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
-н: Snape, M, зэрэг
Хэвлэсэн: (2013)

Penicillin Dalam Pengobatan Infeksi Meningococci
-н: Perpustakaan UGM, i-lib
Хэвлэсэн: (1974)

Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.
-н: Callaghan, M, зэрэг
Хэвлэсэн: (2011)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
-н: Snape, MD, зэрэг
Хэвлэсэн: (2013)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
-н: Li, K, зэрэг
Хэвлэсэн: (2023)

Towards an improved serogroup B Neisseria meningitidis vaccine.
-н: Perrett, K, зэрэг
Хэвлэсэн: (2005)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
-н: Jonathon M. Monroe, зэрэг
Хэвлэсэн: (2022-11-01)

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
-н: Snape, M, зэрэг
Хэвлэсэн: (2015)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
-н: Kan Li, зэрэг
Хэвлэсэн: (2023-02-01)